dronabinol (Marinol)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Marinol. DEA-controlled substance: class 3. (delta-9-tetrahydrocannabinol)

Indications

Dosage

Tabs: 2.5, 5, 10 mg.

Pharmacokinetics

elimination via liver

1/2life = 25-36 hours

protein binding = 94-99 %

Adverse effects

Drug interactions

Laboratory

Mechanism of action

More general terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
  4. 4.0 4.1 Prescriber's Letter 12(6):32 2005 New Drug: Sativex (Delta-9-tetrahydrocannabinol and Cannabidiol) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210605&pb=PRL (subscription needed) http://www.prescribersletter.com
  5. 5.0 5.1 Associated Press Oct 6, 2006
  6. 6.0 6.1 HIGHLIGHTS OF PRESCRIBING INFORMATION MARINOL (dronabinol) capsules, for oral use, CIII https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf

Database